CKD Lab Methods, Progression & Risk Factors 1 (original) (raw)
Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial
Takahiko Nakagawa
Clinical and Experimental Nephrology, 2019
View PDFchevron_right
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
Francesca Viazzi
Clinical Kidney Journal, 2022
View PDFchevron_right
Uric Acid and Long-term Outcomes in CKD
Vandana Menon
American Journal of Kidney Diseases, 2009
View PDFchevron_right
Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease
Friedo Dekker
Nephrology Dialysis Transplantation, 2015
View PDFchevron_right
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
Michel Burnier
Current Hypertension Reports, 2020
View PDFchevron_right
Uric Acid as a Target of Therapy in CKD
Giovanni Targher
American Journal of Kidney Diseases, 2013
View PDFchevron_right
Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease
Chien-ning Hsu
Scientific Reports
View PDFchevron_right
Use of Allopurinol in Slowing the Progression of Renal Disease Through Its Ability to Lower Serum Uric Acid Level
Matthew tong
American Journal of Kidney Diseases, 2006
View PDFchevron_right
Evaluation of Uric Acid and Its Correlation with Decline in Estimated Glomerular Filtration Rate among the Chronic Kidney Disease Patients
fikadu seyoum
2023
View PDFchevron_right
Associations between Hyperuricemia and Chronic Kidney Disease: A Review
Shankar Sah
Nephro-Urology Monthly, 2015
View PDFchevron_right
The grey zone of Hyperuricemia in chronic kidney disease
Periklis Dousdampanis
Journal of Advanced Research, 2017
View PDFchevron_right
Hyperuricemia in Renal patients: Treat or not to treat
Muhammad Tanzeel
Archives of Clinical Nephrology
View PDFchevron_right
Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
Ioannis Stefanidis
Journal of Advanced Research, 2017
View PDFchevron_right
Uric acid in chronic kidney disease
A. Treviño-Becerra
View PDFchevron_right
Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study
Ulrich Neyer
Experimental Gerontology, 2008
View PDFchevron_right
Management of asymptomatic hyperuricemia in chronic kidney disease: A proposed stepwise approach
Anass Qasem
African journal of nephrology, 2022
View PDFchevron_right
The Role of Hyperuricemia in the Pathogenesis and Progressivity of Chronic Kidney Disease
wira mahadita
Open Access Macedonian Journal of Medical Sciences
View PDFchevron_right
J-Shaped Mortality Relationship for Uric Acid in CKD
Jonas Axelsson
American Journal of Kidney Diseases, 2006
View PDFchevron_right
Effect of Allopurinol on Inflammatory Markers in Chronic Kidney Disease Patients with Asymptomatic Hyperuricaemia
Rafiqul Hasan
Journal of Dhaka Medical College, 2017
View PDFchevron_right
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
Elaine Pascoe
Nephrology Dialysis Transplantation, 2013
View PDFchevron_right
High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease
Naowanit Nata, Bancha Satirapoj
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2010
View PDFchevron_right
Archives of Renal Diseases and Management
Ennio Duranti
View PDFchevron_right
Serum Uric Acid Independently Predicts Cardiovascular Events in Advanced Nephropathy
Hilmi Unal
American Journal of Nephrology, 2012
View PDFchevron_right
Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients
Friedo Dekker
BMC nephrology, 2014
View PDFchevron_right
Serum Uric Acid Level and Cardiovascular Disease Development Risk in Stage 3-5 Chronic Kidney Disease Patients
Suleyman Karakose
Düzce Tıp Fakültesi Dergisi, 2020
View PDFchevron_right
Association between serum uric acid and chronic kidney disease in patients with hypertension: A multicenter nationwide cross‐sectional study
Ram Rangsin
Journal of Evidence-Based Medicine, 2019
View PDFchevron_right
Relationship Between Uric Acid Levels and Risk Factor in Hypertensive Patient
Maulana Syarif
2016
View PDFchevron_right
Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
ChaoRong Wu
Antioxidants
View PDFchevron_right
Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions
Ramazan Yigitoglu, Faruk Turgut
International Urology and Nephrology, 2007
View PDFchevron_right
Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study
Jesper Hallas
PLOS ONE, 2016
View PDFchevron_right
Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease ― Japanese Guideline on the Management of Asymptomatic Hyperuricemia ―
Endang Mahati
Circulation Journal
View PDFchevron_right